117 related articles for article (PubMed ID: 19704935)
1. Increased concentrations of serotonin and 5-hydroxyindoleacetic acid in blood plasma from patients with pulmonary hypertension due to mitral valve disease.
Kirillova VV; Nigmatullina RR; Dzhordzhikiya RK; Kudrin VS; Klodt PM
Bull Exp Biol Med; 2009 Apr; 147(4):408-10. PubMed ID: 19704935
[TBL] [Abstract][Full Text] [Related]
2. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
[TBL] [Abstract][Full Text] [Related]
3. Systemic and pulmonary hemodynamic changes immediately following mitral valve replacement in man.
McIlduff JB; Daggett WM; Buckley MJ; Lappas DG
J Cardiovasc Surg (Torino); 1980; 21(3):261-6. PubMed ID: 7391117
[TBL] [Abstract][Full Text] [Related]
4. [Serotonin content in the blood of pulmonary hypertension patients during general anesthesia in closed mitral commissurotomy].
Gimmel'farb GN; Gerasimov NM; Kleĭnerman VE; Khan NI
Anesteziol Reanimatol; 1980; (2):40-3. PubMed ID: 7386934
[No Abstract] [Full Text] [Related]
5. Increased turnover of serotonin in children with pulmonary hypertension secondary to congenital heart disease.
Breuer J; Georgaraki A; Sieverding L; Baden W; Apitz J
Pediatr Cardiol; 1996; 17(4):214-9. PubMed ID: 8662042
[TBL] [Abstract][Full Text] [Related]
6. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Cremer SE; Kristensen AT; Reimann MJ; Eriksen NB; Petersen SF; Marschner CB; Tarnow I; Oyama MA; Olsen LH
Am J Vet Res; 2015 Jun; 76(6):520-31. PubMed ID: 26000599
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of serotonin in platelets in essential hypertension.
Nityanand S; Tekwani BL; Chandra M; Shanker K; Singh BN
Life Sci; 1990; 46(5):367-72. PubMed ID: 1689448
[TBL] [Abstract][Full Text] [Related]
8. A modified HPLC technique for simultaneous measurement of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in cerebrospinal fluid, platelet and plasma.
Kumar AM; Kumar M; Deepika K; Fernandez JB; Eisdorfer C
Life Sci; 1990; 47(19):1751-9. PubMed ID: 1701205
[TBL] [Abstract][Full Text] [Related]
9. [Determination of catechelamines, serotonin, and 5-hydroxyindoleacetic acid in a blood].
Gilonskiĭ MA; Latysheva TV; Semenova LP
Klin Lab Diagn; 2007 Jun; (6):25-8. PubMed ID: 17682477
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the vasodilator effects of prostaglandin E1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome.
Kunimoto F; Arai K; Isa Y; Koyano T; Kadoi Y; Saito S; Goto F
Anesth Analg; 1997 Sep; 85(3):507-13. PubMed ID: 9296401
[TBL] [Abstract][Full Text] [Related]
11. Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement.
Li M; Dumesnil JG; Mathieu P; Pibarot P
J Am Coll Cardiol; 2005 Apr; 45(7):1034-40. PubMed ID: 15808760
[TBL] [Abstract][Full Text] [Related]
12. Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease.
Sekiduka-Kumano T; Kawayama T; Ito K; Shoji Y; Matsunaga K; Okamoto M; Edakuni N; Imaoka H; Uchimura N; Hoshino T
BMC Psychiatry; 2013 May; 13():159. PubMed ID: 23721166
[TBL] [Abstract][Full Text] [Related]
13. Rapid and reliable high-performance liquid chromatographic method for analysing human plasma serotonin, 5-hydroxyindoleacetic acid, homovanillic acid and 3,4-dihydroxyphenylacetic acid.
Cheng FC; Kuo JS; Chang WH; Juang DJ; Shih Y; Lai JS
J Chromatogr; 1993 Aug; 617(2):227-32. PubMed ID: 7691858
[TBL] [Abstract][Full Text] [Related]
14. Determination of plasma serotonin and 5-hydroxyindoleacetic acid in healthy subjects and cancer patients.
Lee MS; Cheng FC; Yeh HZ; Liou TY; Liu JH
Clin Chem; 2000 Mar; 46(3):422-3. PubMed ID: 10702533
[No Abstract] [Full Text] [Related]
15. Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis.
Humbert M; Labrune P; Sitbon O; Le Gall C; Callebert J; Hervé P; Samuel D; Machado R; Trembath R; Drouet L; Launay JM; Simonneau G
Eur Respir J; 2002 Jul; 20(1):59-65. PubMed ID: 12166582
[TBL] [Abstract][Full Text] [Related]
16. [Hemodynamic evaluation of pulmonary hypertension secondary to mitral valve disease].
Ruíz Ros JA; Sogorb Garrí F; Palacios Motilla V; Cebolla Rosell R; Algarra Vidal FJ
Rev Esp Cardiol; 1975; 28(6):517-26. PubMed ID: 1215607
[No Abstract] [Full Text] [Related]
17. Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson's disease are associated with nonmotor symptoms.
Tong Q; Zhang L; Yuan Y; Jiang S; Zhang R; Xu Q; Ding J; Li D; Zhou X; Zhang K
Parkinsonism Relat Disord; 2015 Aug; 21(8):882-7. PubMed ID: 26028271
[TBL] [Abstract][Full Text] [Related]
18. Mitral valve replacement in the presence of severe pulmonary hypertension.
Kaul TK; Bain WH; Jones JV; Lorimer AR; Thomson RM; Turner MA; Escarous A
Thorax; 1976 Jun; 31(3):332-6. PubMed ID: 941120
[TBL] [Abstract][Full Text] [Related]
19. Simplified determination of serotonin in plasma by liquid chromatography with electrochemical detection.
Tagari PC; Boullin DJ; Davies CL
Clin Chem; 1984 Jan; 30(1):131-5. PubMed ID: 6197206
[TBL] [Abstract][Full Text] [Related]
20. [Early postoperative hemodynamic changes after mitral valve substitution].
Lanzillo G; Cellini C; Intonti MA; Pragliola C; Baruffi E
Chir Patol Sper; 1987 Dec; 35(6):137-44. PubMed ID: 3273574
[No Abstract] [Full Text] [Related]
[Next] [New Search]
